Earned Royalties. (a) With respect to Net Sales of a Product resulting from a Development Antibody, on a Product-by-Product basis, TESARO shall pay AnaptysBio a royalty on Net Sales as follows: Worldwide Annual Net Sales of a Product (on a Product-by-Product basis) during the applicable calendar year during the Royalty Term: Royalty Rate Applicable to a Product: Portion less than or equal to $[*]: [*]% Portion greater than $[*], but less than or equal to $[*]: [*]% Portion greater than $[*], but less than or equal to $[*]: [*]% Portion greater than $[*], but less than or equal to $[*]: [*]% Portion greater than $[*]: [*]%
Appears in 4 contracts
Samples: Collaboration and Exclusive License Agreement (Anaptysbio Inc), Collaboration and Exclusive License Agreement (Anaptysbio Inc), Collaboration and Exclusive License Agreement (Anaptysbio Inc)
Earned Royalties. (a) With respect to Net Sales of a Product resulting from a Development Antibody, on a Product-by-Product basis, TESARO shall pay AnaptysBio a royalty on Net Sales as follows: Worldwide Annual Net Sales of a Product (on a Product-by-Product basis) during the applicable calendar year during the Royalty Term: Royalty Rate Applicable to a Product: Portion less than or equal to $[***]: [*]**] % Portion greater than $[***], but less than or equal to $[***]: [*]**] % Portion greater than $[***], but less than or equal to $[***]: [*]**] % Portion greater than $[***], but less than or equal to $[***]: [*]**] % Portion greater than $[***]: [*]**] %
Appears in 1 contract
Samples: Collaboration and Exclusive License Agreement (TESARO, Inc.)
